171 related articles for article (PubMed ID: 66869)
1. Cytotoxic drug-induced lung disease.
Sostman HD; Matthay RA; Putman CE
Am J Med; 1977 Apr; 62(4):608-15. PubMed ID: 66869
[TBL] [Abstract][Full Text] [Related]
2. Review: diagnosis of chemotherapy lung.
Sostman HD; Putman CE; Gamsu G
AJR Am J Roentgenol; 1981 Jan; 136(1):33-40. PubMed ID: 6161531
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary toxicity of antineoplastic drugs.
Willson JK
Cancer Treat Rep; 1978 Dec; 62(12):2003-8. PubMed ID: 87268
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary cytotoxicity induced by bleomycin and methotrexate].
Sheĭkh ZhV; Krutskevich AO; Drebushevskiĭ NS; Shvaĭko SN; Dunaev AP; Alekseev VG
Vestn Rentgenol Radiol; 2015; (3):46-51. PubMed ID: 26302622
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced lung disease.
Limper AH
Clin Chest Med; 2004 Mar; 25(1):53-64. PubMed ID: 15062597
[TBL] [Abstract][Full Text] [Related]
6. Lung damage from cytotoxic drugs.
Collis CH
Cancer Chemother Pharmacol; 1980; 4(1):17-27. PubMed ID: 6153937
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive and cytotoxic chemotherapy: long-term complications.
Schein PS; Winokur SH
Ann Intern Med; 1975 Jan; 82(1):84-95. PubMed ID: 67817
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced lung disease.
Whitcomb ME
Chest; 1973 Mar; 63(3):418-22. PubMed ID: 4120558
[No Abstract] [Full Text] [Related]
9. Pulmonary effects of cytotoxic agents other than bleomycin.
Twohig KJ; Matthay RA
Clin Chest Med; 1990 Mar; 11(1):31-54. PubMed ID: 1691069
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of drug-induced pulmonary disease.
Rosenow EC
Ann Intern Med; 1972 Dec; 77(6):977-91. PubMed ID: 4118760
[No Abstract] [Full Text] [Related]
11. [Pulmonary accidents following treatments with immunodepressive agents].
Coury C; Saltiel JC
Rev Prat; 1972 Jan; 22(3):319-28. PubMed ID: 5029700
[No Abstract] [Full Text] [Related]
12. [Respiratory pathology of immunosuppressive drugs. History, classification and clinical study].
Coury C; Saltiel JC
Rev Tuberc Pneumol (Paris); 1972; 36(5):743-61. PubMed ID: 4662344
[No Abstract] [Full Text] [Related]
13. [Pulmonary changes due to bleomycin. Radiologic study].
Dragoni G; Guzzon A; Bonadonna G
Radiol Med; 1971 Jul; 57(7):497-510. PubMed ID: 4112551
[No Abstract] [Full Text] [Related]
14. Ambroxol and pulmonary toxicity induced by antineoplastic drugs.
Luisetti M; Peona V; Salmona M; Pagnoni AM; Villani F; Knerich R; Genghini M; Abbà L; Pozzi E
Int J Clin Pharmacol Res; 1986; 6(2):129-36. PubMed ID: 2424848
[TBL] [Abstract][Full Text] [Related]
15. The pulmonary changes of bleomycin toxicity.
Horowitz AL; Friedman M; Smith J; Yagoda A; LaMonte C; Watson RC
Radiology; 1973 Jan; 106(1):65-8. PubMed ID: 4118845
[No Abstract] [Full Text] [Related]
16. Elevation of the erythrocyte sedimentation rate precedes exacerbation of bleomycin-induced pulmonary toxicity: report of two cases and review of literature.
Higa GM; AlKhouri N; Auber ML
Pharmacotherapy; 1997; 17(6):1315-21. PubMed ID: 9399618
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic drug-induced pulmonary disease: update 1980.
Weiss RB; Muggia FM
Am J Med; 1980 Feb; 68(2):259-66. PubMed ID: 6153504
[TBL] [Abstract][Full Text] [Related]
18. [Toxic effects on the lung: is "pneumonia" caused by drugs?].
Bischoff A
MMW Fortschr Med; 2009 Jun; 151(26-29):20-1. PubMed ID: 19739540
[No Abstract] [Full Text] [Related]
19. Pulmonary complications of cytostatic medication.
Meinesz D; Seldenrath JJ
Radiol Clin Biol; 1973; 42(2):175-6. PubMed ID: 4124586
[No Abstract] [Full Text] [Related]
20. The role of screening and monitoring for bleomycin pulmonary toxicity.
Shippee BM; Bates JS; Richards KL
J Oncol Pharm Pract; 2016 Apr; 22(2):308-12. PubMed ID: 25736276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]